Posted by Michael Wonder on 30 Nov 2024
FDA approves updated drug labelling for fludarabine phosphate under Project Renewal
19 November 2024 - Today, the FDA approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection, Sandoz) under Project Renewal, an Oncology Center of Excellence initiative aimed at updating labelling information for certain older oncology drugs to ensure information is clinically meaningful and scientifically up to date.
This is the third medicine to receive a labelling update under Project Renewal.
